Sekisui Chemical Co., Ltd. (SKSUF)

Kronos Bio Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	86,845	142,586	138,572	101,080	144,534	87,454
Short-Term Investments	16,724	-	-	-	-	-
Cash & Short-Term Investments	103,569	142,586	138,572	101,080	144,534	87,454
Cash Growth	-3.54%	2.90%	37.09%	-30.06%	65.27%	13.84%
Accounts Receivable	188,438	205,094	211,197	190,815	184,490	169,459
Receivables	189,007	205,808	212,312	190,929	184,672	169,461
Inventory	321,193	313,817	298,232	286,799	243,837	222,909
Prepaid Expenses	8,792	7,389	5,793	8,414	8,092	7,121
Other Current Assets	28,777	33,504	30,655	34,428	28,260	18,626
Total Current Assets	651,338	703,104	685,564	621,650	609,395	505,571
Property, Plant & Equipment	412,457	403,870	392,485	377,381	365,254	351,397
Long-Term Investments	106,631	158,901	180,776	166,899	165,471	188,565
Goodwill	6,541	6,874	8,636	11,028	10,736	50,914
Other Intangible Assets	53,490	52,257	50,461	39,975	35,997	46,735
Long-Term Deferred Tax Assets	5,696	4,855	4,223	10,034	10,909	5,347
Other Long-Term Assets	53,240	2	1	1	2	1
Total Assets	1,290,432	1,330,786	1,323,243	1,228,131	1,198,921	1,150,143
Accounts Payable	100,307	123,551	123,858	136,603	138,181	117,594
Accrued Expenses	53,394	66,961	63,209	60,729	63,499	61,775
Short-Term Debt	2,727	2,340	11,569	3,569	4,293	7,278
Current Portion of Long-Term Debt	10,000	-	30	-	-	-
Current Portion of Leases	5,490	5,422	5,433	5,156	5,000	4,625
Current Income Taxes Payable	9,295	16,870	25,086	11,817	23,678	10,658
Other Current Liabilities	139,053	124,858	115,412	110,104	95,043	80,348
Total Current Liabilities	320,266	340,002	344,597	327,978	329,694	282,278
Long-Term Debt	75,965	86,042	86,270	96,217	98,093	111,207
Long-Term Leases	17,786	17,025	17,421	15,515	15,170	15,057
Long-Term Deferred Tax Liabilities	1,534	1,524	4,757	4,046	4,624	10,362
Other Long-Term Liabilities	7,856	8,004	7,930	9,121	6,749	6,446
Total Liabilities	465,795	495,421	502,319	495,608	496,170	455,752
Common Stock	100,002	100,002	100,002	100,002	100,002	100,002
Additional Paid-In Capital	105,073	105,068	108,621	108,583	109,042	109,021
Retained Earnings	532,815	544,799	501,945	468,094	447,958	441,087
Treasury Stock	-52,432	-50,082	-48,679	-46,637	-44,592	-43,414
Comprehensive Income & Other	110,307	107,560	130,440	74,983	62,225	60,370
Total Common Equity	795,765	807,347	792,329	705,025	674,635	667,066
Minority Interest	28,872	28,018	28,595	27,498	28,116	27,325
Shareholders' Equity	824,637	835,365	820,924	732,523	702,751	694,391
Total Liabilities & Equity	1,290,432	1,330,786	1,323,243	1,228,131	1,198,921	1,150,143
Total Debt	111,968	110,829	120,723	120,457	122,556	138,167
Net Cash (Debt)	-8,399	31,757	17,849	-19,377	21,978	-50,713
Net Cash Growth	-	77.92%	-	-	-	-
Net Cash Per Share	-20.31	75.95	42.02	-44.53	49.31	-112.21
Filing Date Shares Outstanding	413.63	417.54	421.39	429.2	436.08	448.93
Total Common Shares Outstanding	413.63	417.54	421.39	429.2	444.08	448.93
Working Capital	331,072	363,102	340,967	293,672	279,701	223,293
Book Value Per Share	1923.88	1933.56	1880.29	1642.67	1519.19	1485.89
Tangible Book Value	735,734	748,216	733,232	654,022	627,902	569,417
Tangible Book Value Per Share	1778.75	1791.94	1740.05	1523.83	1413.95	1268.38
Order Backlog	-	180,998	139,200	164,300	185,000	184,800

Source: S&P Global Market Intelligence. Standard template. Financial Sources.